In a regulatory filing, Incyte chief medical officer Steven Stein disclosed the sale of 11,608 common shares of the company on August 12 at a price of $60.63 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY: